Haematinga (200 ml) Syrup | Price, Usage, Dosage, Composition, and Brand Substitutes - Fixed-Dose Combination (FDC) Drug
Haematinga (200 ml) Syrup
Haematinga (200 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Inga Laboratories Pvt. Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Ferrous Fumarate, Cyanocobalamin,Folic Acid (Vit B9),Sorbitol. This drug comes in the form of Syrup. The general packing available for this medicine consists of 200 ml and is priced at Rs 57.2 (arround $0.8008 US Dollar)| Generic (Salt) Combination : | (Ferrous Fumarate+ Cyanocobalamin+Folic Acid (Vit B9)+Sorbitol) |
| Pharma Company : | Inga Laboratories Pvt. Ltd. |
| Brand Label : | Haematinga (200 ml) |
| Preparation Type : | Syrup |
| Single Dose : | 5 ml |
| Composition (Fixed-Dose Combination) : |
|
| Pack Size/Qty/Vol : | 200 ml |
| Price Unit : | Rs 1.43 INR (arround $0.02002 US Dollar) |
| Price Pack : | Rs 57.2 INR (arround $0.8008 US Dollar) |
Drug details for Haematinga (200 ml)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Haematinga (200 ml) are :
Ferrous Fumarate
Indication (Prescribed for or used as): iron-deficiency anaemia
For more details on Ferrous Fumarate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Ferrous Fumarate..
CyanocobalaminIndication (Prescribed for or used as): in the treatment of megaloblastosis
For more details on Cyanocobalamin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Cyanocobalamin..
Folic Acid (Vit B9)Indication (Prescribed for or used as): Folate-deficient. Megaloblastic anaemia. Prophylaxis of megaloblastic anemia in pregnancy. Prophylaxis of neural tube defect in pregnancy. Malabsorption syndromes. Antiepileptic therapy.
For more details on Folic Acid (Vit B9), its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Folic Acid (Vit B9)..
SorbitolIndication (Prescribed for or used as):
For more details on Sorbitol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Sorbitol..
Haematinga (200 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Haematinga (200 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Ferrous Fumarate-110 mg Folic Acid (Vit B9)-1.5 mg Cyanocobalamin-15 mcg Sorbitol-10% w/v).Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.
| Brand | Price (Rs.) | Brand | Price (Rs.) |
Haematinga (200 ml) Syrup
Haematinga (200 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Inga Laboratories Pvt. Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Cyanocobalamin, Ferrous Fumarate,Folic Acid (Vit B9),Sorbitol. This drug comes in the form of Syrup. The general packing available for this medicine consists of 200 ml and is priced at Rs 57.2 (arround $0.8008 US Dollar)| Generic (Salt) Combination : | (Cyanocobalamin+ Ferrous Fumarate+Folic Acid (Vit B9)+Sorbitol) |
| Pharma Company : | Inga Laboratories Pvt. Ltd. |
| Brand Label : | Haematinga (200 ml) |
| Preparation Type : | Syrup |
| Single Dose : | 5 ml |
| Composition (Fixed-Dose Combination) : |
|
| Pack Size/Qty/Vol : | 200 ml |
| Price Unit : | Rs 1.43 INR (arround $0.02002 US Dollar) |
| Price Pack : | Rs 57.2 INR (arround $0.8008 US Dollar) |
Drug details for Haematinga (200 ml)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Haematinga (200 ml) are :
Cyanocobalamin
Indication (Prescribed for or used as): in the treatment of megaloblastosis
For more details on Cyanocobalamin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Cyanocobalamin..
Ferrous FumarateIndication (Prescribed for or used as): iron-deficiency anaemia
For more details on Ferrous Fumarate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Ferrous Fumarate..
Folic Acid (Vit B9)Indication (Prescribed for or used as): Folate-deficient. Megaloblastic anaemia. Prophylaxis of megaloblastic anemia in pregnancy. Prophylaxis of neural tube defect in pregnancy. Malabsorption syndromes. Antiepileptic therapy.
For more details on Folic Acid (Vit B9), its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Folic Acid (Vit B9)..
SorbitolIndication (Prescribed for or used as):
For more details on Sorbitol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Sorbitol..
Haematinga (200 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Haematinga (200 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Folic Acid (Vit B9)-1.5 mg Cyanocobalamin-15 mcg Sorbitol-10% w/v Ferrous Fumarate-110 mg).Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.
| Brand | Price (Rs.) | Brand | Price (Rs.) |